Prostaglandins and the lung.
Evidence exists implicating prostaglandins as mediators of asthma and of chronic inflammation in the lung. In addition to their spasmogenic effects, PGs are also potent in vitro regulators of mediator secretion by basophils, mast cells, or lymphocytes. These regulatory effects of E-series PGs may have considerable significance in drug design and evaluation in both asthma and chronic inflammation.
D001249:Asthma / Q000503:physiopathology*; D006801:Humans; D008168:Lung / Q000503:physiopathology; D011014:Pneumonia / Q000503:physiopathology*; D011458:Prostaglandins E / Q000378:metabolism / Q000502:physiology*
D011458:Prostaglandins E